Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort.
Adrian CiureaEleftherios PapagiannoulisKristina BürkiIsabell von LogaRaphael MicheroliBurkhard MöllerAndrea Rubbert-RothMichael AndorRené BrämAngela MüllerDiana DanDiego KyburzOliver DistlerAlmut SchererAxel FinckhPublished in: Annals of the rheumatic diseases (2020)
A short interruption of in-person patient-rheumatologist interactions had no major detrimental impact on the disease course of axSpA, RA and PsA as assessed by patient-reported outcomes.